This pathway consists of three sequential enzymes: phosphoserine aminotransferase 1 (PSAT1), phosphoserine phosphatase (PSPH), and PHGDH, the rate‐limiting enzyme extensively studied as a cancer therapy target (Figure 4). The gene discussed is PHGDH; the disease is cancer.